Article Summary
陈民彪 潘和 王德伟 黎亮 廖绪强.全胸腔镜肺叶切除联合淋巴结清扫术治疗老年非小细胞肺癌患者的临床研究[J].现代生物医学进展英文版,2015,15(24):4719-4722.
全胸腔镜肺叶切除联合淋巴结清扫术治疗老年非小细胞肺癌患者的临床研究
Thoracoscopic Lobectomy Combined with Lymph Node Dissection forElderly Patients with Non-small Cell Lung Cancer
  
DOI:
中文关键词: 非小细胞肺癌  全胸腔镜肺叶切除术  淋巴结清扫术  高龄
英文关键词: Non-small cell lung cancer  Thoracoscopic lobectomy  Lymph node dissection  Elderly
基金项目:
Author NameAffiliation
陈民彪 潘和 王德伟 黎亮 廖绪强 海南省人民医院胸外科 
Hits: 653
Download times: 0
中文摘要:
      目的:了解全胸腔镜肺叶切除联合淋巴结清扫术治疗老年非小细胞肺癌病人的临床效果。方法:选取我院2009 年2 月到 2011 年2月接受全胸腔镜肺叶切除联合淋巴结清扫术治疗的老年非小细胞肺癌患者共102 例,其中高龄组(≧70 岁)24 例;非高 龄组(<70 岁)78 例。观察两组手术时间、手术中的出血量、术后的住院时间、术后的输血量、胸液总量、胸管放置时间、术后并发 症、止痛药使用的次数等情况,并对两组患者进行随访了解其早期生存情况。结果:两组手术时间、术中出血量、术后输血量、术后 住院时间、胸液的总量、胸管放置的时间、止痛药的使用次数、术后的并发症、平均的淋巴结数和淋巴结转移情况比较均无统计学 差异(P>0.05)。非高龄组1 年生存率为98.1%,2 年生存率为80.3%,高龄组1 年生存率为95.3%,2 年生存率为73.1%,非高龄组 与高龄组早期生存状况比较无统计学意义差异(P>0.05)。结论:采用全胸腔镜肺叶切除联合淋巴结清扫术治疗非小细胞肺癌病 人,与非高龄病人进行比较,高龄病人能获得同样的治疗疗效和早期预后,所以,可在临床上采纳。
英文摘要:
      Objective:To study the clinical efficacy of thoracoscopic lobectomy combined with lymph nodes dissection in the treatment of elderly patients with non-small cell lung cancer.Methods:A total of 102 elderly patients with non-small cell lung cancer (NSCLC), who underwent thoracoscopic lobectomy combined with lymph nodes dissection in People's Hospital of Hainan Province from February 2009 to February 2011, were selected and divided into non-elderly group (<70 years old, n=78) and elderly group (≧70 years old, n=24). Then the operation time, intraoperative blood loss, postoperative blood transfusion, postoperative hospitalization time, chest tube placement time, chest fluid volume, painkiller usage, postoperative complications were observed; all the patients were followed up to understand their early survival status.Results:There were no significant differences in operation time, intraoperative blood loss, postoperative blood transfusion, postoperative hospitalization time, chest tube placement time, chest fluid volume, pain killer usage, postoperative complications, average lymph nodes and lymph node metastasis between the two groups (P>0.05). The 1-year and 2-year survival rate in non-elderly group was 98.1%and 80.3%; the 1-year and 2-year survival rate in elderly group was 95.3%and 73.1%.There was no significant difference in the early survival status between the two groups(P>0.05).Conclusion:Thoracoscopic lobectomy combined with lymph node dissection in the treatment of elderly patients with NSCLC can obtain the same clinical efficacy and early prognosis, compared with non-elderly group which can be applied to the clinical field.
View Full Text   View/Add Comment  Download reader
Close